SCHEMBL24378540

SCHEMBL24378540

Bc1nc2nc(Cl)cc(Cl)n2n1

nearest known ligand 0.44

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.44
CKS1B P61024 1/20 0.30
SKP2 Q13309 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27009148 0.76 PDE10A (0.40) PDE10ACKS1BSKP2
SCHEMBL24378542 0.71 CYP1A2 (0.42) PDE10A
SCHEMBL20511355 0.69 TDP1 (0.49) PDE10A
SCHEMBL20511288 0.68 SMN1; SMN2 (0.47) PDE10A
SCHEMBL7984951 0.67 SMN1; SMN2 (0.33) PDE10A
SCHEMBL9680379 0.65 KDM4E (0.46) PDE10A
SCHEMBL23413440 0.65 KDM4E (0.59)
SCHEMBL21630207 0.62 HSD11B1 (0.42)
SCHEMBL23649060 0.61 PDE10A (0.50) PDE10A
SCHEMBL1934522 0.60 PDE10A (0.48) PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022086993-A1 NOVEL INHIBITORS OF PIKFYVE AND METHODS USING SAME TME THERAPEUTICS LLC (US) 2022-04-28 WO disclosed